find the medians, preimium/discount rate to median, company level %, imaging %, diagnostics %, advance therapies %, total multiple values, value of equity and value per share.

Please solve for ALL the GREEN SHADED areas. There should be a value and a formula for each (excel formula please)

Transcribed Image Text:

Discount rate Growth rate after 2032 Note: This sets the growth rate for beyond 2032. Long term Explict forecasts based on business analysis Transition period to steady-state assumptions Steady state 2018 2019 2020 2021 2022 Revenue growth EBIT margin Tax rate 3.2% 4.3% 4.7% 4.7% 2023 4.2% 2024 2025 2026 2027 2028 2029 2030 2031 2032 3.8% 3.3% 2.8% 2.3% 1.9% 1.4% 0.9% 0.5% 0.0% 16.8% 17.8% 18.3% 18.8% 19.3% 19.8% 20.3% 20.8% 21.0% 21.0% 21.0% 21.0% 21.0% 21.0% 27.7% 27.9% 28.1% 28.2% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% D&A as % of revenue 4.2% 4.1% 4.1% 4.0% 3.9% 3.8% 3.7% 3.6% 3.5% 3.4% 3.3% 3.2% 3.1% 3.0% Working capital as % revenue 21.0% 20.6% 20.2% 19.8% 19.4% 19.1% 18.8% 18.5% 18.4% 18.2% 18.1% 18.0% 18.0% 17.9% 18.0% Capex as % revenue 4.7% 4.5% 4.4% 4.3% 4.2% 4.0% 3.9% 3.8% 3.6% 3.5% 3.4% 3.3% 3.1% 3.0% Working capital 2,786.91 Change in working capital Revenue EBIT Taxes Net operating profit after tax 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 13,271 1,855 490 1,365 add D&A 559 subtract increase in working capital -127 subtract capex 636 Free cash flow (FCF) Value as of end of fiscal 2018 % of Total PV FCF through 2022 PV FCF 2023-32, transition PV of terminal value Enterprise value subtract net debt subtract minority interests subtract unfunded pension liability Value of equity Number of shares Value per share (EUR) 1,000 Termin 2032 ( Discount rate Growth rate after 2032 Note: This sets the growth rate for beyond 2032. Long term Explict forecasts based on business analysis Transition period to steady-state assumptions Steady state 2018 2019 2020 2021 2022 Revenue growth EBIT margin Tax rate 3.2% 4.3% 4.7% 4.7% 2023 4.2% 2024 2025 2026 2027 2028 2029 2030 2031 2032 3.8% 3.3% 2.8% 2.3% 1.9% 1.4% 0.9% 0.5% 0.0% 16.8% 17.8% 18.3% 18.8% 19.3% 19.8% 20.3% 20.8% 21.0% 21.0% 21.0% 21.0% 21.0% 21.0% 27.7% 27.9% 28.1% 28.2% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% 29.0% D&A as % of revenue 4.2% 4.1% 4.1% 4.0% 3.9% 3.8% 3.7% 3.6% 3.5% 3.4% 3.3% 3.2% 3.1% 3.0% Working capital as % revenue 21.0% 20.6% 20.2% 19.8% 19.4% 19.1% 18.8% 18.5% 18.4% 18.2% 18.1% 18.0% 18.0% 17.9% 18.0% Capex as % revenue 4.7% 4.5% 4.4% 4.3% 4.2% 4.0% 3.9% 3.8% 3.6% 3.5% 3.4% 3.3% 3.1% 3.0% Working capital 2,786.91 Change in working capital Revenue EBIT Taxes Net operating profit after tax 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 13,271 1,855 490 1,365 add D&A 559 subtract increase in working capital -127 subtract capex 636 Free cash flow (FCF) Value as of end of fiscal 2018 % of Total PV FCF through 2022 PV FCF 2023-32, transition PV of terminal value Enterprise value subtract net debt subtract minority interests subtract unfunded pension liability Value of equity Number of shares Value per share (EUR) 1,000 Termin 2032 (